Daisuke Uchida
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Daisuke Uchida has a total of 67 co-authors. Here are the top co-authors by number of shared publications:
- Sho Sasaki
Clinical research support office, Iizuka Hospital, Iizuka City, Japan
4 shared publications Hiroo Kawarazaki
Department of Nephrology, Inagi Municipal Hospital, Inagi City, Japan
3 shared publicationsYugo Shibagaki
3 shared publications- Hiroki Nishiwaki
Division of Nephrology, Department of Medicine; Showa Medical University Fujigaoka Hospital; Yokohama Japan
2 shared publications - Hiroo Kawarazaki
Department of Internal Medicine, Teikyo University Hospital Mizonokuchi, Kawasaki, Japan
2 shared publications Kenichiro Koitabashi
2 shared publications
Latest Publications
- 1 May 2018
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 33 (suppl_1) , i447-i448
SP307BETA BLOCKER AND RENIN-ANGIOTENSIN SYSTEM INHIBITORS AS THE CAUSE OF HYPERKALEMIA; A CROSS SECTIONAL STUDY
INTRODUCTION AND AIMS: As renal dysfunction progresses, the incidence of hyperkalemia rises. Although there are several case reports and case series on hyperkalemia caused by β blockers, few epidemiological studies have verified the relationship between beta blockers and hyperkalemia. On the other hand, it is well-known that renin-angiotensin system inhibitors (RAS-i) raise serum potassium levels. The actual effect of the use of a combination of β blocker and RAS-i on serum potassium levels is not clear when compared with RAS-i use only, beta blocker use only, or neither. Objective The objective of this study was to assess the association between β blocker and RAS-i use, and hyperkalemia among patients with near end-stage renal disease (ESRD).
- 1 May 2018
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 33 (suppl_1) , i447-i448
SP307BETA BLOCKER AND RENIN-ANGIOTENSIN SYSTEM INHIBITORS AS THE CAUSE OF HYPERKALEMIA; A CROSS SECTIONAL STUDY
INTRODUCTION AND AIMS: As renal dysfunction progresses, the incidence of hyperkalemia rises. Although there are several case reports and case series on hyperkalemia caused by β blockers, few epidemiological studies have verified the relationship between beta blockers and hyperkalemia. On the other hand, it is well-known that renin-angiotensin system inhibitors (RAS-i) raise serum potassium levels. The actual effect of the use of a combination of β blocker and RAS-i on serum potassium levels is not clear when compared with RAS-i use only, beta blocker use only, or neither. Objective The objective of this study was to assess the association between β blocker and RAS-i use, and hyperkalemia among patients with near end-stage renal disease (ESRD).
- 1 July 2017
- Published by Wolters Kluwer Health in ASAIO Journal
- Vol. 63 (4) , 501-506
Systemic Inflammatory Response Syndrome Is Not an Indicator of Bacteremia in Hemodialysis Patients With Native Accesses: A Multicenter Study
Bloodstream infection (BSI) in hemodialysis (HD) patients is often difficult to diagnose. Systemic inflammatory response syndrome (SIRS) is a sensitive predictor of BSI in the general population. We aimed to assess the usefulness of SIRS in predicting BSI in HD patients. We designed a multicenter retrospective observational study of adult (age > 18 years) HD patients who underwent two sets of blood cultures for suspected BSI at first hospital visit from August 2011 to July 2012. Clinical, biological, and microbial data were evaluated to evaluate SIRS as a predictor of BSI upon initial presentation to the hospital. Data were obtained from 279 HD patients. Vascular access other than arteriovenous fistula and subcutaneously fixed superficial artery, and those administered antimicrobial drugs before visit were excluded; thus, a total of 202 patients were finally enrolled. Mean patient age was 71 years, 67.3% were male, 49.3% had diabetes, 28.2% had indwelling hardware, and 18.3% patients had BSI. Endocarditis and vertebral osteomyelitis were common infection sites, and Staphylococcus aureus was the most common pathogen. Of those with SIRS, 25.3% had BSI and 74.7% did not (odds ratio for SIRS, 2.10; 95% confidence interval, 0.90-4.91; p = 0.11). Thus, SIRS had a low sensitivity for predicting BSI in HD patients (sensitivity, 71.9%; specificity, 45.2%; positive likelihood ratio, 1.31; negative likelihood ratio, 0.62). Systemic inflammatory response syndrome has low sensitivity in identifying BSI in HD patients. A low threshold for drawing blood cultures and initiating antibiotic treatment should be considered for HD patients.
- 1 July 2017
- Published by Wolters Kluwer Health in ASAIO Journal
- Vol. 63 (4) , 501-506
Systemic Inflammatory Response Syndrome Is Not an Indicator of Bacteremia in Hemodialysis Patients With Native Accesses: A Multicenter Study
Bloodstream infection (BSI) in hemodialysis (HD) patients is often difficult to diagnose. Systemic inflammatory response syndrome (SIRS) is a sensitive predictor of BSI in the general population. We aimed to assess the usefulness of SIRS in predicting BSI in HD patients. We designed a multicenter retrospective observational study of adult (age > 18 years) HD patients who underwent two sets of blood cultures for suspected BSI at first hospital visit from August 2011 to July 2012. Clinical, biological, and microbial data were evaluated to evaluate SIRS as a predictor of BSI upon initial presentation to the hospital. Data were obtained from 279 HD patients. Vascular access other than arteriovenous fistula and subcutaneously fixed superficial artery, and those administered antimicrobial drugs before visit were excluded; thus, a total of 202 patients were finally enrolled. Mean patient age was 71 years, 67.3% were male, 49.3% had diabetes, 28.2% had indwelling hardware, and 18.3% patients had BSI. Endocarditis and vertebral osteomyelitis were common infection sites, and Staphylococcus aureus was the most common pathogen. Of those with SIRS, 25.3% had BSI and 74.7% did not (odds ratio for SIRS, 2.10; 95% confidence interval, 0.90-4.91; p = 0.11). Thus, SIRS had a low sensitivity for predicting BSI in HD patients (sensitivity, 71.9%; specificity, 45.2%; positive likelihood ratio, 1.31; negative likelihood ratio, 0.62). Systemic inflammatory response syndrome has low sensitivity in identifying BSI in HD patients. A low threshold for drawing blood cultures and initiating antibiotic treatment should be considered for HD patients.
- 12 May 2017
- Published by Wiley in Therapeutic Apheresis and Dialysis
- Vol. 21 (4) , 354-360
Association Between Staphylococcus aureus Bacteremia and Hospital Mortality in Hemodialysis Patients With Bloodstream Infection: A Multicenter Cohort From Japanese Tertiary Care Centers
Multiple studies have shown that Staphylococcus aureus bacteremia (SAB) has been a major cause of death in hemodialysis patients. We examined whether SAB is a risk for mortality among chronic hemodialysis patients in Japan where the standard vascular access is arteriovenous fistula (AVF). This was a multicenter, retrospective study of maintenance hemodialysis patients with bloodstream infection (BSI) from 2011 to 2013 at tertiary care centers in Japan. The endpoint was hospital mortality. Our cohort contained 32 SAB cases (14 MRSA and 18 MSSA) and 42 non-SAB cases. Hospital mortality was higher among SAB cases than non-SAB cases (46.9% vs. 23.8%, P = 0.038). In patients with BSI, SAB was significantly associated with hospital mortality after adjustment for potential confounders, including type of vascular access (OR 3.26). S. aureus was the leading cause of BSI and hospital mortality among this cohort. Therefore, initial empiric treatment should cover for S. aureus.
- 12 May 2017
- Published by Wiley in Therapeutic Apheresis and Dialysis
- Vol. 21 (4) , 354-360
Association Between Staphylococcus aureus Bacteremia and Hospital Mortality in Hemodialysis Patients With Bloodstream Infection: A Multicenter Cohort From Japanese Tertiary Care Centers
Multiple studies have shown that Staphylococcus aureus bacteremia (SAB) has been a major cause of death in hemodialysis patients. We examined whether SAB is a risk for mortality among chronic hemodialysis patients in Japan where the standard vascular access is arteriovenous fistula (AVF). This was a multicenter, retrospective study of maintenance hemodialysis patients with bloodstream infection (BSI) from 2011 to 2013 at tertiary care centers in Japan. The endpoint was hospital mortality. Our cohort contained 32 SAB cases (14 MRSA and 18 MSSA) and 42 non-SAB cases. Hospital mortality was higher among SAB cases than non-SAB cases (46.9% vs. 23.8%, P = 0.038). In patients with BSI, SAB was significantly associated with hospital mortality after adjustment for potential confounders, including type of vascular access (OR 3.26). S. aureus was the leading cause of BSI and hospital mortality among this cohort. Therefore, initial empiric treatment should cover for S. aureus.
- Open Access
- 1 May 2017
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 32 (suppl_3) , iii219-iii221
SP331CHRONIC KIDNEY DISEASE AND THE ASSOCIATION OF SELF-ASSESSED LIFESTYLE BEHAVIORS WITH MORTALITY IN A LARGE JAPANESE GENERAL POPULATION
INTRODUCTION AND AIMS: Only a few studies have addressed the association of dietary or exercise habits with mortality in CKD patients. Further, it remains unknown whether the associations are different from those in non-CKD general population.
- 1 May 2017
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 32 (suppl_3) , iii219-iii221
Open AccessSP331CHRONIC KIDNEY DISEASE AND THE ASSOCIATION OF SELF-ASSESSED LIFESTYLE BEHAVIORS WITH MORTALITY IN A LARGE JAPANESE GENERAL POPULATION
INTRODUCTION AND AIMS: Only a few studies have addressed the association of dietary or exercise habits with mortality in CKD patients. Further, it remains unknown whether the associations are different from those in non-CKD general population.
- 24 August 2014
- Published by Springer Nature in Clinical and Experimental Nephrology
- Vol. 19 (3) , 474-480
Underestimating chronic kidney disease by urine dipstick without serum creatinine as a screening tool in the general Japanese population
It is not known if urine dipstick alone can identify chronic kidney disease (CKD) in the general Japanese population.
- 24 August 2014
- Published by Springer Nature in Clinical and Experimental Nephrology
- Vol. 19 (3) , 474-480
Underestimating chronic kidney disease by urine dipstick without serum creatinine as a screening tool in the general Japanese population
It is not known if urine dipstick alone can identify chronic kidney disease (CKD) in the general Japanese population.
- 27 June 2013
- Published by Wolters Kluwer Health in Transplantation
- Vol. 95 (12) , e78-e79
A Case of Campylobacter Enteritis in a Renal Transplant Recipient
- 27 June 2013
- Published by Wolters Kluwer Health in Transplantation
- Vol. 95 (12) , e78-e79
A Case of Campylobacter Enteritis in a Renal Transplant Recipient
- Vol. 32, 7-10
Correlation Between Near-Vision Acuity and the Incidence of Peritoneal Dialysis-Related Infections.
Peritoneal dialysis (PD)-related infections (PDIs) such as peritonitis, exit-site infection, and tunnel infection are serious complications affecting patients on PD. Because patients with diabetes (DM) and of older age have increased in number in Japan, the number of patients with visual impairment is estimated also to have increased. Near vision is necessary for performing proper PD daily care. However, no studies have reported whether visual impairment is likely to increase the risk of PDIs.Our study included 31 PD patients (16 men, 15 women; mean age: 61.5 ± 11.8 years; mean PD duration: 27.3 ± 20.3 months; 38.7% with DM; 54.8% wearing glasses) who performed their own PD care. At our facility and related facilities, we used a standard near-vision test chart, which classifies vision into 12 grades, from 0.1 (poor) to 1.5 (clear), to assess near-vision binocular visual acuity in those patients between March 2015 and September 2015. In addition, we retrospectively examined the medical records of the patients to determine their history of PDIs. We then evaluated the correlation between near-vision acuity and the incidence of PDIs.Mean measured near-vision acuity was 0.61 ± 0.29, and we observed no significant difference in the visual acuity of patients with and without DM (0.55 ± 0.31 vs. 0.63 ± 0.26 respectively, p = 0.477). In addition, we observed no significant difference in the incidence of PDIs between patients with and without DM (1.298 ± 1.609 per year vs. 1.164 ± 0.908 per year respectively, p = 0.804). We did not find a correlation between near-vision acuity and the incidence of PDIs (r = -0.071, p = 0.795).
- Vol. 32, 7-10
Correlation Between Near-Vision Acuity and the Incidence of Peritoneal Dialysis-Related Infections.
Peritoneal dialysis (PD)-related infections (PDIs) such as peritonitis, exit-site infection, and tunnel infection are serious complications affecting patients on PD. Because patients with diabetes (DM) and of older age have increased in number in Japan, the number of patients with visual impairment is estimated also to have increased. Near vision is necessary for performing proper PD daily care. However, no studies have reported whether visual impairment is likely to increase the risk of PDIs.Our study included 31 PD patients (16 men, 15 women; mean age: 61.5 ± 11.8 years; mean PD duration: 27.3 ± 20.3 months; 38.7% with DM; 54.8% wearing glasses) who performed their own PD care. At our facility and related facilities, we used a standard near-vision test chart, which classifies vision into 12 grades, from 0.1 (poor) to 1.5 (clear), to assess near-vision binocular visual acuity in those patients between March 2015 and September 2015. In addition, we retrospectively examined the medical records of the patients to determine their history of PDIs. We then evaluated the correlation between near-vision acuity and the incidence of PDIs.Mean measured near-vision acuity was 0.61 ± 0.29, and we observed no significant difference in the visual acuity of patients with and without DM (0.55 ± 0.31 vs. 0.63 ± 0.26 respectively, p = 0.477). In addition, we observed no significant difference in the incidence of PDIs between patients with and without DM (1.298 ± 1.609 per year vs. 1.164 ± 0.908 per year respectively, p = 0.804). We did not find a correlation between near-vision acuity and the incidence of PDIs (r = -0.071, p = 0.795).